citalopram has been researched along with Acute Ischemic Stroke in 5 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A secondary analysis of data from the multicentre randomised controlled trial The Efficacy of Citalopram Treatment in Acute Ischemic Stroke (TALOS)." | 9.69 | Impact of prestroke physical activity and citalopram treatment on poststroke depressive symptoms: a secondary analysis of data from the TALOS randomised controlled trial in Denmark. ( Andersen, G; Blauenfeldt, RA; Damsbo, AG; Johnsen, SP; Mortensen, JK; Vestergaard, SB, 2023) |
| "This study aims to investigate the effects of escitalopram on neural functional prognoses and endothelial dysfunction after acute ischemic stroke." | 9.34 | Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction. ( Cao, JX; Chen, JC; Liu, L; Sun, YT; Yang, ZD; Zeng, QH, 2020) |
| "Citalopram-treated animals (n = 13) showed a significant increase in impaired forepaw use in the staircase task compared with saline-treated animals (n = 12) 2, 3 and 7 weeks post stroke but no difference in neurological score at any time point examined." | 5.72 | Delayed citalopram administration reduces brain inflammation and enhances skilled motor function after ischaemic stroke in 'MacGreen' mice. ( Bennet, L; Chen, S; McGregor, AL, 2022) |
| "A secondary analysis of data from the multicentre randomised controlled trial The Efficacy of Citalopram Treatment in Acute Ischemic Stroke (TALOS)." | 5.69 | Impact of prestroke physical activity and citalopram treatment on poststroke depressive symptoms: a secondary analysis of data from the TALOS randomised controlled trial in Denmark. ( Andersen, G; Blauenfeldt, RA; Damsbo, AG; Johnsen, SP; Mortensen, JK; Vestergaard, SB, 2023) |
| "We studied the correlation between prestroke PA and poststroke cognitive performance in a prespecified analysis in The Efficacy of Citalopram Treatment in Acute Ischemic Stroke (TALOS) trial." | 5.34 | Prestroke Physical Activity and Poststroke Cognitive Performance. ( Andersen, G; Blauenfeldt, RA; Damsbo, AG; Johnsen, SP; Kraglund, KL; Mortensen, JK, 2020) |
| "This study aims to investigate the effects of escitalopram on neural functional prognoses and endothelial dysfunction after acute ischemic stroke." | 5.34 | Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction. ( Cao, JX; Chen, JC; Liu, L; Sun, YT; Yang, ZD; Zeng, QH, 2020) |
| "Citalopram-treated animals (n = 13) showed a significant increase in impaired forepaw use in the staircase task compared with saline-treated animals (n = 12) 2, 3 and 7 weeks post stroke but no difference in neurological score at any time point examined." | 1.72 | Delayed citalopram administration reduces brain inflammation and enhances skilled motor function after ischaemic stroke in 'MacGreen' mice. ( Bennet, L; Chen, S; McGregor, AL, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S | 1 |
| Bennet, L | 1 |
| McGregor, AL | 1 |
| Vestergaard, SB | 1 |
| Damsbo, AG | 2 |
| Blauenfeldt, RA | 2 |
| Johnsen, SP | 2 |
| Andersen, G | 2 |
| Mortensen, JK | 2 |
| Pigretti, SG | 1 |
| Isaac, C | 1 |
| Cea, C | 1 |
| Esnaola, MM | 1 |
| Riveros, M | 1 |
| Tejada Jacob, V | 1 |
| Weinberg, M | 1 |
| Posadas Martinez, ML | 1 |
| Cirelli, D | 1 |
| Burgos, MA | 1 |
| Zimerman, M | 1 |
| Romano, M | 1 |
| Kraglund, KL | 1 |
| Cao, JX | 1 |
| Liu, L | 1 |
| Sun, YT | 1 |
| Zeng, QH | 1 |
| Yang, ZD | 1 |
| Chen, JC | 1 |
1 review available for citalopram and Acute Ischemic Stroke
| Article | Year |
|---|---|
[Pharmacological treatment in early rehabilitation after ischemic stroke].
Topics: Amitriptyline; Antipsychotic Agents; Citalopram; Humans; Ischemic Stroke; Medicine | 2023 |
3 trials available for citalopram and Acute Ischemic Stroke
| Article | Year |
|---|---|
Impact of prestroke physical activity and citalopram treatment on poststroke depressive symptoms: a secondary analysis of data from the TALOS randomised controlled trial in Denmark.
Topics: Aged; Brain Ischemia; Citalopram; Denmark; Depression; Exercise; Female; Humans; Ischemic Stroke; Ma | 2023 |
Prestroke Physical Activity and Poststroke Cognitive Performance.
Topics: Aged; Citalopram; Cognition; Cognitive Dysfunction; Disability Evaluation; Double-Blind Method; Exer | 2020 |
Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction.
Topics: Acute Disease; Aged; Cerebral Infarction; Citalopram; Endothelium, Vascular; Female; Humans; Ischemi | 2020 |
1 other study available for citalopram and Acute Ischemic Stroke
| Article | Year |
|---|---|
Delayed citalopram administration reduces brain inflammation and enhances skilled motor function after ischaemic stroke in 'MacGreen' mice.
Topics: Animals; Brain Ischemia; Citalopram; Disease Models, Animal; Encephalitis; Ischemic Stroke; Mice; Ne | 2022 |